Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

IRIS Toxicological Review of Chloroprene (Final Report)

On this page:

  • Overview
  • History
  • Downloads
The final Toxicological Review of Chloroprene provides scientific support and rationale for the hazard and dose-response assessment pertaining to chronic exposure to chloroprene. Chloroprene (C4H5Cl) is a volatile, flammable liquid used primarily in the manufacture of polychloroprene or neoprene rubber. The latter is used to make diverse products, such as tires, wire coatings, and tubing. Human health risk concerns for chloroprene are primarily related to exposures via effluent and emissions from facilities that use chloroprene to produce polychloroprene elastomers or transport the product, although these exposure concerns have not been well characterized.

This assessment contains the derivation of a chronic inhalation reference concentration (RfC) and chronic cancer inhalation unit risk.

Impact/Purpose

Chloroprene (CASRN 126-99-8) or 2-chloro-1,3-butadiene is a volatile liquid monomer used exclusively in the manufacture of polychloroprene (neoprene) elastomer.

Citation

U.S. EPA. IRIS Toxicological Review of Chloroprene (Final Report). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-09/010F, 2010.

History/Chronology

Date Description
01- 1999 The IRIS reassessment of chloroprene was initiated in 1999. Currently there is no entry in the IRIS database for chloroprene.
02- Sep 2009 EPA released the external review draft for public review and comment.
03- Nov 2009 EPA announced the public listening session to be held on November 23, 2009 in a November 5, 2009 Federal Register Notice.
04- Dec 2009 EPA announced an external peer review workshop to be held on January 6, 2010 in a December 1, 2009 Federal Register Notice.
05- Feb 2010 EPA released the comments from the public comment period and external review workshop.
06- Jul 2010 EPA hosted an interagency science discussion on the review of the draft Toxicological Review of Chloroprene.
07- Sep 2010 EPA released the final toxicological report and IRIS Summary for Chloroprene and the interagency science discussion draft with comments.

Download(s)

This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

  • IRIS Toxicological Review of Chloroprene (PDF)  (303  pp, 3.0 MB, about PDF)
  • IRIS Summary for Chloroprene (PDF)  (30  pp, 259.8 KB, about PDF)

Related Link(s)

  • IRIS Toxicological Review of Chloroprene (External Review Draft)
  • IRIS Toxicological Review of Chloroprene (Interagency Science Discussion Draft)
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on February 02, 2017
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.